Johnson & Johnson controlled the plant’s control of the dose Million dose of the vacuum against COVID-19

Washington. Johnson & johnson n ‘vrag the supervision of a plant by the manufacturer Emergent BioSolutions, donating 15 million doses of the vaccine of the pharmaceutical pharmaceuticals against the covid-19 product during production.

This is what the New York Times diary has to say, indicating that it was dealing with an “extraordinary media” from the Department of Health and Human Services (HHS, in English), after it was revealed that it had been installed in Baltimore (Maryland) makes Johnson & Johnson and AstraZeneca pharmaceuticals ingredients.

However, the decision was taken that the laboratory did not produce the AstraZeneca vaccine, which had not received the Emergency Food Authorization (FDA) authorization for distribution to EE.UU.

In a statement, Johnson & Johnson pointed out that this is “asda the responsibility for the manufacture of pharmacological substances for the covid-19 vaccine in the installations of Emergent BioSolutions Inc. Bayview”.

“The company is a growing leader dedicated to operations and quality, and significantly increases the number of manufacturing operations staff, quality and techniques to work with the company’s specialists who are in Emergency”, according to the municipality.

The pharmacy with seats in New Brunswick (New Jersey) points out that the doses of its vaccine distributed are close to the “he complies with the standards of the quality of the company and the normative” and previews that Mayo finals will be “near 100 million individual doses ”in the Government of the United States.

“The company is currently working closely with the Food and Drug Administration of the United States to obtain the Emergency Use (EUA) authorization of Emergent Bayview facilities,” he said.

On Wednesday, the state-of-the-art company informed that it had identified a lot “that does not comply with the standards of quality in Emergent Biosolutions” and stated that it “did not go through the stages of preparation and improvement” of its manufacturing process.

According to the note, the plant is not authorized to manufacture the pharmacy for its use.

For its part, the neoorquino diary ensures that the FDA has not been involved in distributing any of the Johnson & Johnson doses manufactured by Emergent, and it is estimated that the plant will receive the authorization to distribute some of the doses it produces .

The Emergent plant, signaling the rotation, received 628 million dollars in June of this year as part of the initiative led by the Donald Trump administration to roll out vacancies against the coronavirus.

This installation was contracted by Johnson & Johnson and AstraZeneca, including the version.

United States accumulates 30,668,826 cases of coronavirus SARS-CoV-2 and 554,779 cases of covid-19 disease.

According to the Control Centers for Disease Prevention (CDC), 104.2 million people (31.4% of the population) received at least one dose of the vaccine, of those 59.8 million (18%) they are completely inoculated.